Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemfibrozil for Nicotine Dependence
NCT01876810Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Feb 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Gemfibrozil with Placebo (2 arms). Primary endpoint: Number of Days With Self-report of No Smoking and Breath Carbon Monoxide of <5 PPM During Quit-attempt Weeks at 1 week. Started Feb 2014; status: completed.
02
Drugs
gemfibrozil
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01876810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876810.